UBS AM’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9M Buy
1,589,368
+488,822
+44% +$7.02M ﹤0.01% 902
2025
Q4
$17M Buy
1,100,546
+55,501
+5% +$1.02M ﹤0.01% 904
2025
Q3
$22.6M Sell
1,045,045
-116,582
-10% -$2.6M ﹤0.01% 783
2025
Q2
$25.8M Buy
1,161,627
+649,821
+127% +$14.4M 0.01% 940
2025
Q1
$12.2M Sell
511,806
-43,348
-8% -$1.03M ﹤0.01% 1148
2024
Q4
$11.8M Sell
555,154
-23,394
-4% -$614K ﹤0.01% 1177
2024
Q3
$18.7M Sell
578,548
-1,768
-0.3% -$52.2K ﹤0.01% 977
2024
Q2
$13.8M Buy
580,316
+65,810
+13% +$1.69M ﹤0.01% 1006
2024
Q1
$15.3M Buy
514,506
+19,064
+4% +$596K 0.01% 873
2023
Q4
$15.8M Buy
495,442
+98,078
+25% +$2.85M 0.01% 836
2023
Q3
$11.6M Buy
397,364
+9,519
+2% +$342K 0.01% 910
2023
Q2
$13.4M Hold
387,845
0.01% 866
2023
Q1
$13.4M Buy
387,845
+3,494
+0.9% +$113K 0.01% 866
2022
Q4
$10.7M Buy
384,351
+62,456
+19% +$1.65M 0.01% 915
2022
Q3
$7.53M Sell
321,895
-51,536
-14% -$1.65M ﹤0.01% 1057
2022
Q2
$10.8M Sell
373,431
-9,946
-3% -$435K 0.01% 931
2022
Q1
$21.1M Sell
383,377
-17,423
-4% -$862K 0.01% 833
2021
Q4
$21.4M Sell
400,800
-12,462
-3% -$578K 0.01% 882
2021
Q3
$17.5M Buy
413,262
+378,797
+1,099% +$19.3M 0.01% 905
2021
Q2
$2.3M Buy
34,465
+8,313
+32% +$451K ﹤0.01% 1786
2021
Q1
$1.16M Buy
26,152
+3,084
+13% +$115K ﹤0.01% 2020
2020
Q4
$669K Hold
23,068
﹤0.01% 2178
2020
Q3
$505K Buy
23,068
+9,968
+76% +$177K ﹤0.01% 2139
2020
Q2
$152K Buy
+13,100
New +$144K ﹤0.01% 2425
2016
Q4
Sell
-15,200
Closed -$308K 2636
2016
Q3
$308K Hold
15,200
﹤0.01% 2253
2016
Q2
$272K Buy
+15,200
New +$226K ﹤0.01% 2273

Other funds holding SGRY